Indication

Renal Tubular

1 clinical trial

1 product

Clinical trial

A Phase 3B Open-Label Extension Of Study B23CS (ARENA 2) Evaluating The Continued Safety And Efficacy Of ADV7103 In Subjects With Primary Distal Renal Tubular Acidosis

Status: Withdrawn, Estimated PCD: 2025-01-01

Product